U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
189331189331Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid TumorsWithdrawnNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: gemcitabine|Drug: soblidotin|Procedure: chemotherapyhttps://ClinicalTrials.gov/show/NCT00072228
189332189332Cisplatin and Ifosfamide Combined With Either Paclitaxel or Vinblastine in Treating Men With Progressive or Recurrent Metastatic Germ Cell TumorsTerminatedNo Results AvailableExtragonadal Germ Cell Tumor|Testicular Germ Cell TumorDrug: cisplatin|Drug: ifosfamide|Drug: paclitaxel|Drug: vinblastinehttps://ClinicalTrials.gov/show/NCT00072215
189333189333A Phase II Study of UCN-01 in Metastatic MelanomaTerminatedHas ResultsRecurrent Melanoma|Stage IV MelanomaDrug: 7-hydroxystaurosporine|Other: laboratory biomarker analysis|Other: pharmacological studyhttps://ClinicalTrials.gov/show/NCT00072189
189334189334Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial CancerCompletedHas ResultsEndometrial Adenocarcinoma|Endometrial Adenosquamous Cell Carcinoma|Endometrial Clear Cell Carcinoma|Endometrial Papillary Serous Carcinoma|Recurrent Endometrial Carcinoma|Stage IIIA Endometrial Carcinoma|Stage IIIB Endometrial Carcinoma|Stage IIIC EndomeDrug: temsirolimus|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00072176
189335189335Temozolomide and Thalidomide in Treating Patients With Brain Metastases Secondary to MelanomaCompletedNo Results AvailableRecurrent Melanoma|Stage IV Melanoma|Tumors Metastatic to BrainDrug: temozolomide|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00072163
189336189336Phase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell CarcinomaCompletedNo Results AvailableMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Bladder Cancer|Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter|Recurrent Urethral Cancer|Stage III Bladder Cancer|Stage III Urethral Cancer|Stage IV Bladder CanDrug: bortezomibhttps://ClinicalTrials.gov/show/NCT00072150
189337189337Neoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing CystectomyTerminatedNo Results AvailableBladder Adenocarcinoma|Bladder Squamous Cell Carcinoma|Bladder Urothelial Carcinoma|Recurrent Bladder Carcinoma|Stage I Bladder Cancer|Stage II Bladder Cancer|Stage III Bladder Cancer|Stage IV Bladder CancerBiological: Recombinant Fowlpox-TRICOM Vaccine|Biological: Recombinant Fowlpox GM-CSF Vaccine Adjuvant|Procedure: Therapeutic Conventional Surgery|Other: Pharmacological Study|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00072137
189338189338Dacarbazine and/or Cisplatin Compared With Complete Metastasectomy in Treating Patients With Stage IV MelanomaCompletedNo Results AvailableMelanoma (Skin)Drug: cisplatin|Drug: dacarbazine|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00072124
189339189339Anakinra in Treating Patients With Metastatic Cancer Expressing the Interleukin-1 GeneCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificBiological: anakinrahttps://ClinicalTrials.gov/show/NCT00072111
189340189340Interleukin-12 Gene in Treating Patients With Liver Metastases Secondary to Colorectal CancerRecruitingNo Results AvailableColorectal Cancer|Metastatic CancerBiological: adenovirus vector|Biological: interleukin-12 genehttps://ClinicalTrials.gov/show/NCT00072098
189341189341Immunization With gp100 Protein Vaccine in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: aldesleukin|Biological: gp100 antigen|Biological: incomplete Freund's adjuvanthttps://ClinicalTrials.gov/show/NCT00072085
189342189342Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerDrug: celecoxib|Drug: erlotinib hydrochloridehttps://ClinicalTrials.gov/show/NCT00072072
189343189343Ro 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNo Results AvailableAnemia|Lung CancerBiological: methoxy polyethylene glycol epoetin betahttps://ClinicalTrials.gov/show/NCT00072059
189344189344Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)CompletedNo Results AvailableKidney CancerBiological: bevacizumab|Biological: recombinant interferon alfahttps://ClinicalTrials.gov/show/NCT00072046
189345189345Neoadjuvant Docetaxel and Cisplatin Plus Chemoradiotherapy Followed By Surgery in Treating Patients With Locally Advanced, Resectable Esophageal CancerCompletedNo Results AvailableEsophageal CancerDrug: Cisplatin and Docetaxelhttps://ClinicalTrials.gov/show/NCT00072033
189346189346Chemotherapy and/or Hormone Therapy With or Without Zoledronate in Treating Women With Stage II or Stage III Breast CancerActive, not recruitingNo Results AvailableBreast Cancer|Metastatic CancerDrug: zoledronic acid|Procedure: adjuvant therapy|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00072020
189347189347Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLLCompletedNo Results AvailableLeukemiaBiological: filgrastim|Biological: rituximab|Drug: CHOP regimen|Drug: cladribine|Drug: cyclophosphamide|Drug: doxorubicin hydrochloride|Drug: prednisone|Drug: vincristine sulfatehttps://ClinicalTrials.gov/show/NCT00072007
189348189348Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)CompletedNo Results AvailableAdult Primary Hepatocellular Carcinoma|Advanced Adult Primary Liver Cancer|Localized Unresectable Adult Primary Liver Cancer|Recurrent Adult Primary Liver CancerDrug: gefitinib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00071994
189349189349Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic MelanomaActive, not recruitingHas ResultsMelanoma (Skin)Biological: incomplete Freund's adjuvant|Biological: melanoma helper peptide vaccine|Biological: multi-epitope melanoma peptide vaccine|Biological: sargramostim|Biological: tetanus peptide melanoma vaccinehttps://ClinicalTrials.gov/show/NCT00071981
189350189350Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of RelapseCompletedNo Results AvailableProstate CancerDrug: temsirolimus|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00071968
189351189351Vaccine Therapy and Sargramostim After Rituximab in Treating Patients With Refractory or Progressive Non-Hodgkin's LymphomaCompletedNo Results AvailableLymphomaBiological: autologous immunoglobulin idiotype-KLH conjugate vaccine|Biological: sargramostimhttps://ClinicalTrials.gov/show/NCT00071955
189352189352Vaccine Therapy in Treating Patients With Metastatic Breast CancerTerminatedNo Results AvailableMale Breast Cancer|Recurrent Breast Cancer|Stage IV Breast CancerBiological: recombinant vaccinia-MUC1 vaccine|Biological: recombinant vaccinia-TRICOM vaccine|Other: laboratory biomarker analysis|Procedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00071942
189353189353Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNo Results AvailableEndometrial CancerDrug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00071929
189354189354Racial Difference in HCV/Host InteractionsRecruitingNo Results AvailableHepatitis Chttps://ClinicalTrials.gov/show/NCT00071916
189355189355The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control StudyCompletedNo Results AvailablePseudotumor Cerebri|Cystinosishttps://ClinicalTrials.gov/show/NCT00071903
189356189356Phase II/III Study Evaluating the Effect of IL-2 on Preservation of the CD4 T-Lymphocytes After Interruption of Antiretroviral Treatment in HIV-Infected Patients With CD4 T-Lymphocyte Count Greater Than 500 Cells/mm3 Who Received Antiretroviral TxCompletedHas ResultsHIV InfectionsDrug: Interleukin 2|Drug: HAART|Drug: Treatment interruptionhttps://ClinicalTrials.gov/show/NCT00071890
189357189357An Open-Label Clinical Trial of Replagal Enzyme Therapy in Children Ages 7-17 Years With Fabry DiseaseCompletedNo Results AvailableFabry DiseaseDrug: Replagalhttps://ClinicalTrials.gov/show/NCT00071877
189358189358Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected AdultsCompletedNo Results AvailableHIV InfectionsBiological: VRC-HIVDNA009-00-VPhttps://ClinicalTrials.gov/show/NCT00071851
189359189359Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple SclerosisCompletedNo Results AvailableMultiple Sclerosis, Relapsing-RemittingDrug: Daclizumabhttps://ClinicalTrials.gov/show/NCT00071838
189360189360A Safety and Efficacy Study of LymphoStat-Bâ„¢ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)CompletedHas ResultsArthritis, RheumatoidDrug: Placebo|Drug: Belimumab 1 mg/kg|Drug: Belimumab 4 mg/kg|Drug: Belimumab 10 mg/kghttps://ClinicalTrials.gov/show/NCT00071812

* Görseller ve İçerik tekif hakkına sahip olabilir